Pimozide (Standard)
CAT:
804-HY-12987R-01
Size:
5 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Pimozide (Standard)
Description:
Pimozide (Standard) is the analytical standard of Pimozide. This product is intended for research and analytical applications. Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5.Product Name Alternative:
R6238 (Standard)UNSPSC:
12352005Hazard Statement:
H302-H361Target:
Adrenergic Receptor; Dopamine Receptor; Parasite; Reference Standards; STATType:
Reference StandardsRelated Pathways:
Anti-infection; GPCR/G Protein; JAK/STAT Signaling; Neuronal Signaling; Others; Stem Cell/WntField of Research:
Cancer; Neurological Disease; EndocrinologyAssay Protocol:
https://www.medchemexpress.com/pimozide-standard.htmlPurity:
99.81Smiles:
O=C1NC2=CC=CC=C2N1C3CCN (CCCC (C4=CC=C (F) C=C4) C5=CC=C (F) C=C5) CC3Molecular Formula:
C28H29F2N3OMolecular Weight:
461.55Precautions:
P264-P270-P280-P330-P405-P501References & Citations:
[1]Ybema CE, et al. Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan. Eur J Pharmacol. 1994 Apr 21;256 (2) :141-7.|[2]Cai N, et al. The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression. Am J Transl Res. 2017 Aug 15;9 (8) :3853-3866. eCollection 2017.|[3]Erik A. Nelson, et al. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood. 2011 Mar 24; 117 (12) : 3421-3429.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, sealed storage, away from light and moistureScientific Category:
Reference StandardsClinical Information:
LaunchedCAS Number:
2062-78-4
